NP_001231005.1
[Other Products]
NCBI GenBank Nucleotide #
|
[Other Products]
UniProt Primary Accession #
|
[Other Products]
UniProt Secondary Accession #
UniProt Related Accession #
Molecular Weight
35,464 Da
NCBI Official Full Name
DNA repair protein RAD51 homolog 3
NCBI Protein Information
DNA repair protein RAD51 homolog 3
UniProt Protein Name
DNA repair protein RAD51 homolog 3
UniProt Synonym Protein Names
RAD51 homolog C; RAD51-like protein 2
UniProt Synonym Gene Names
UniProt Comments for RAD51C
Essential for the homologous recombination (HR) pathway of DNA repair. Involved in the homologous recombination repair (HRR) pathway of double-stranded DNA breaks arising during DNA replication or induced by DNA-damaging agents. Part of the RAD21 paralog protein complexes BCDX2 and CX3 which act at different stages of the BRCA1-BRCA2-dependent HR pathway. Upon DNA damage, BCDX2 seems to act downstream of BRCA2 recruitment and upstream of RAD51 recruitment; CX3 seems to act downstream of RAD51 recruitment; both complexes bind predominantly to the intersection of the four duplex arms of the Holliday junction (HJ) and to junction of replication forks. The BCDX2 complex was originally reported to bind single-stranded DNA, single-stranded gaps in duplex DNA and specifically to nicks in duplex DNA. The BCDX2 subcomplex RAD51B:RAD51C exhibits single-stranded DNA-dependent ATPase activity suggesting an involvement in early stages of the HR pathway. Involved in RAD51 foci formation in response to DNA damage suggesting an involvement in early stages of HR probably in the invasion step. Has an early function in DNA repair in facilitating phosphorylation of the checkpoint kinase CHEK2 and thereby transduction of the damage signal, leading to cell cycle arrest and HR activation. Participates in branch migration and HJ resolution and thus is important for processing HR intermediates late in the DNA repair process; the function may be linked to the CX3 complex. Part of a PALB2-scaffolded HR complex containing BRCA2 and which is thought to play a role in DNA repair by HR. Protects RAD51 from ubiquitin-mediated degradation that is enhanced following DNA damage. Plays a role in regulating mitochondrial DNA copy number under conditions of oxidative stress in the presence of RAD51 and XRCC3. Contributes to DNA cross-link resistance, sister chromatid cohesion and genomic stability. Involved in maintaining centrosome number in mitosis.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice. It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Pathways associated with RAD51C recombinant protein
Diseases associated with RAD51C recombinant protein
Disease Name |
Pubmed Publications |
Breast Neoplasms Antibodies |
>47 publications with RAD51C and Breast Neoplasms |
Ovarian Neoplasms Antibodies |
>36 publications with RAD51C and Ovarian Neoplasms |
Fanconi Anemia Antibodies |
>27 publications with RAD51C and Fanconi Anemia |
Anemia Antibodies |
>27 publications with RAD51C and Anemia |
Cell Transformation, Neoplastic Antibodies |
>4 publications with RAD51C and Cell Transformation, Neoplastic |
Adenocarcinoma Antibodies |
>3 publications with RAD51C and Adenocarcinoma |
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 3 Antibodies |
>3 publications with RAD51C and BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 3 |
Carcinoma, Squamous Cell Antibodies |
>3 publications with RAD51C and Carcinoma, Squamous Cell |
Pancreatic Neoplasms Antibodies |
>2 publications with RAD51C and Pancreatic Neoplasms |
Neoplasms, Experimental Antibodies |
>2 publications with RAD51C and Neoplasms, Experimental |
|